Clinical Trials Directory

Trials / Completed

CompletedNCT02482558

Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Unilever R&D · Industry
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the effect of a one week high versus low glycaemic index dietary intervention on hepatic glycogen and lipid levels and blood hormone levels in a two way cross overs study and to see if there is any correlation between this and satiety or appetite.

Detailed description

8 Healthy subject will be scanned the start and end of a 7 day high versus low glycaemic in diet with a 4 week washout between arms. During scan days the hepatic glycogen response to a corresponding high versus low glycaemic index test meal will be measured using 13C Magnetic resonance spectroscopy (MRS) to explore any acute changes in metabolic response. Baseline liver lipid levels will be measured using 1H MRS to explore any long term changes in liver lipid levels. Blood samples will also be obtained throughout the test day to measure for blood glucose, insulin and blood hormone response. Satiety surveys will also be taken throughout the test day and during the diet week. The main hypothesis is that a one week calorie matched Glycaemic index varied diet will result in an altered response of liver glycogen levels acutely following a meal and also longer term hepatic liver lipid levels. A secondary hypothesis is that there will also be associated changes in blood sugar and hormone levels and that all these changes will have an effect on satiety levels in subjects.

Conditions

Interventions

TypeNameDescription
OTHERHigh/Low Glycaemic index test breakfastHigh/Low Glycaemic index test breakfast on test days for a High/Low Glycaemic index 7-day diet

Timeline

Start date
2013-02-01
Primary completion
2013-07-01
Completion
2014-12-01
First posted
2015-06-26
Last updated
2015-06-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02482558. Inclusion in this directory is not an endorsement.